Symyx Technologies — Merger or Acquisition (June 2010)
27 slides from Symyx Technologies's merger presentation, Jun 18, 2010
Slide 1: Symyx and Accelrys: Creating a New Leader in Scientific Informatics Software
Symyx and Accelrys: Creating a New Leader in Scientific Informatics Software June 2010
Slide 2: Forward-Looking Statements
Forward-Looking Statements Statements in this presentation regarding future events or results, such as expected synergies from the merger and projected addressable markets, are forward-looking statements under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act o
Slide 3: Symyx Technologies, Inc.
Symyx Technologies, Inc. SMMX (NASDAQ) 2009 financials > $150.4M revenue > $20.2M adjusted EBITDA > $0.19 non-GAAP diluted earnings/share Debt free with $79M in cash at 3/31/10 Markets Served > Pharmaceutical and Biotech > Chemicals and Energy > Consumer and Industrial Products In 2010, Symyx will c
Slide 4: Electronic Laboratory Environment: ELN is the Scientist's Portal
Electronic Laboratory Environment ELN is the Scientist’s Portal to the Electronic Lab Symyx Scientific Databases Search and find data In-House Databases External Databases Design experiments Monitor experiments Collaborate with other Scientists Analyze results Register structures, reactions and othe
Slide 5: Symyx Software and Scientific Databases
Symyx Software and Scientific Databases Symyx software and scientific databases power laboratories with the information that generates insight, enhances collaboration, and drives productivity. Information-Driven R&D > # 1 market position in – Decision support software – Chemical sourcing databases –
Slide 6: Symyx Powers Electronic Laboratories
Symyx Powers Electronic Laboratories Customers by Industry Rank ELN Decision Support Cheminformatics Databases █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ █ About 1,000 company accounts, and about 50,000 users.
Slide 7: US$ TAM by Industry for ELN in R&D
$US TAM by Industry for ELN in R&D Industry Total ELN Revenue Biopharma $450M Non-Defense Government $250M Academic R&D $250M Chemicals, Energy & Materials $150M Other Industrials $150M Food & Beverage $50M TOTAL CURRENT ESTIMATE* $1.3B Source: Atrium Research & Consulting LLC Biopharmaceuticals is
Slide 8: Enhanced Ability to Benefit from Industry Trends
Enhanced Ability to Benefit from Industry Trends $100M SAM $200M SAM $300M SAM Estimated annualized growth: Overall market ≈ 20%; Software license ≈ 15%; Service/support ≈ 30% Source: Atrium Research & Consulting LLC for 2006 through 2010; 2011 through 2017 projections by Symyx
Slide 9: ELN for R&D Domain Adoption and Market Size
ELN for R&D Domain Adoption and Market Size No. 1 Market Position No. 2 or 3 Market Position DMPK* Market Position 2010 Symyx Market Position by Domain INTRODUCTION GROWTH MATURITY 50% Product Life Cycle Stage DMPK* Formulations Bioanalytical Pharmacology Process Chemistry Synthetic Chemistry <$50M
Slide 10: Transaction Overview
Transaction Overview
Slide 11: Compelling Strategic Rationale
Compelling Strategic Rationale • Creates the leading enterprise scientific informatics software system company • Leverages the capability of managing end-to-end scientific workflows to achieve better outcomes • Utilizes deep expertise in chemistry, biology and materials science and broad scientific
Slide 12: Global Customer Portfolio; Minimal Product Overlap
Global Customer Portfolio; Minimal Product Overlap Customer Synergies Complementary Product Lines Accelrys + Symyx has over 1,350 unique customers including • 29 of the top 30 biopharmaceutical companies • 5 of the top 5 chemical companies • 5 of the top 5 aerospace companies • 3 of the top 5 CPG co
Slide 13: Vibrant & Growing Partner Ecosystem
Vibrant & Growing Partner Ecosystem Electronic Lab Notebook Scientific Information Management Decision Support And Analytics Workflow Automation Reporting, Visualization And Collaboration Scientific Informatics Software System Additional applications and solutions developed by partner community More
Slide 14: Creating a Scientific Informatics System
Creating a Scientific Informatics System Decision Support Analytics Workflow Automation Reporting, Visualization & Collaboration Scientific Information Management Scientific Desktop Scientists R&D Manager Lab Manager VP of R&D Head of IT & Informatics Chemistry Engineering Biology Modeling & Simulat
Slide 15: Combining Industry Leaders
Combining Industry Leaders Founded: 2001 Public: ACCL (NASDAQ) FY 2010 Revenue: $83.0M Leading positions in: § Data Collection and Analysis § Data Access, Integration & Transformation § Scientific Modeling and Simulation § Workflow Automation and Optimization Employees: 370 Headquarters: San Diego,
Slide 16: Key Terms
Key Terms Merger Agreement Tax-free, all stock merger of equals Exchange Ratio Symyx stockholders to receive 0.7802 shares of Accelrys common stock for each share of Symyx they own Ownership Each company’s stockholders will own approximately 50% of combined company Approvals Merger approved by both
Slide 17: Pro Forma Financials
Pro Forma Financials Market Capitalization Combined market cap of ~ $335M (pre-announcement) Combined market cap of ~ $379M (as of June 16, 2010) Cash Position Cash of ~$150M, net of estimated transaction costs Debt None Expected Synergies For calendar 2011, the combined company expects to achieve f
Slide 18: Focused Tactical Plan
Focused Tactical Plan 0-30 Days 180 Days 2011 2011- 2012 • Closing Transaction • Complete Integration & Extraction of Cost Synergies • Drive Organic Revenue Growth • Follow-on Strategic Acquisitions
Slide 19: Thorough Board Evaluation Process and Clear Roadmap to Completion
Thorough Board Evaluation Process and Clear Roadmap to Completion
Slide 20: Symyx Board Carefully Assessed and Negotiated the Transaction with Accelrys
Symyx Board Carefully Assessed and Negotiated the Transaction with Accelrys • Symyx’s board, in consultation with its independent financial and legal advisors, undertook a comprehensive review of the potential benefits and structure of a combination with Accelrys • In negotiating the terms of the me
Slide 21: Comprehensive Board Process - Considered Multiple Proposals
Comprehensive Board Process - Considered Multiple Proposals • Since signing the merger agreement with Accelrys on April 5, 2010 (the “Accelrys Agreement”), the Symyx board reviewed five proposals from Certara/Vector (starting at $6.00 per share and ending with $6.75 per share) and one proposal from
Slide 22: Comprehensive Board Process - Considered Multiple Proposals
Comprehensive Board Process - Considered Multiple Proposals • On May 24, 2010, Certara/Vector submitted a revised proposal to acquire all of the outstanding capital stock of Symyx for $6.75 per share in cash • Revised proposal included: list of due diligence requests, equity commitment letter from V
Slide 23: Comprehensive Board Process - Considered Multiple Proposals
Comprehensive Board Process - Considered Multiple Proposals • On June 8, 2010, Symyx delivered to Certara a form of merger agreement and Vector guaranty, which included the protections and certainty provisions referenced above • During the week of June 7, 2010, Symyx provided Certara/Vector access t
Slide 24: Comprehensive Board Process - Considered Multiple Proposals
Comprehensive Board Process - Considered Multiple Proposals • On June 15, 2010, Symyx’s board concluded Certara/Vector revoked its previous offer to purchase the Company for $6.75 per share in cash and concluded that the indication that Certara would submit a new proposal on unspecified terms is not
Slide 25: Clear Roadmap to Completion
Clear Roadmap to Completion • Cleared Hart-Scott-Rodino waiting period • Subject to approval by Accelrys and Symyx stockholders • Accelrys stockholders to vote at Special Meeting on June 30, 2010 • Symyx stockholders to vote at Special Meeting on June 30, 2010 • Transaction scheduled to close in ear
Slide 26: Important Additional Information and Where to Find It
Important Additional Information and Where to Find It This communication is being made in respect of the proposed business combination involving Accelrys and Symyx. In connection with the proposed transaction, Accelrys has filed a Registration Statement on Form S-4 containing a joint proxy statement
Slide 27: Symyx and Accelrys: Creating a New Leader in Scientific Informatics Software
Symyx and Accelrys: Creating a New Leader in Scientific Informatics Software June 2010
Symyx Technologies — Merger or Acquisition (June 2010) on 6ix